On May 15 – May 18, 2022, this poster was on display at ISPOR 2022.
What is the Objective of this Poster?
- Results provide insights into real-world treatment patters for AA within a diverse set of US healthcare settings.
- ILCS and TCS were by far the most common therapies, with increased prescription of TCS observed over recent years.
- As new treatments are developed introduced, future analyses would be helpful to understand uptake of therapies and prescription patterns among AA patients
Register to view this poster now!